CEO Robert Ford also plans to expand sales of the company’s Lingo over-the-counter glucose sensors after a limited rollout.

A pair of investor calls on Jan. 22 added clarity to the rapidly evolving cardiac ablation market with Abbott Laboratories and Johnson & Johnson providing updates on their pulsed field ablation ...

Continuing a cascade of positive news for Stereotaxis Inc., the company reported the first order for its petite Genesisx ...

Abbott Laboratories ABT is set to report fourth-quarter fiscal 2024 results on Jan. 22. See the Zacks Earnings Calendar to stay ahead of market-making news. For fourth-quarter fiscal 2024, Abbott ...

In 2024, Abbott's EP business demonstrated strength thanks to its preferred mapping systems, even though it is late to market with its own pulsed field ablation technology. However, EP growth ...

Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...

was used with the Abbott TactiCath™ Sensor Enabled, Boston Scientific INTELLANAV STABLEPOINT™, and Johnson & Johnson THERMOCOOL SMARTTOUCH™ ablation catheters. Paroxysmal and persistent AF ...